Page last updated: 2024-08-20

phthalocyanine and Ovarian Neoplasms

phthalocyanine has been researched along with Ovarian Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Astilean, S; Borlan, R; Campu, A; Focsan, M; Gaina, L; Maniu, D; Marc, G; Perde-Schrepler, M; Silion, M; Stoia, D1
Ali, K; Attia, MS; Darwish, WM; El-Kemary, M1
Choyke, PL; Hanaoka, H; Kobayashi, H; Nakajima, T; Sato, K; Watanabe, R1
Cronk, LM; Escalante, CA; Jones, CV; Khalimonchuk, O; Palmer, AL; Schumann, C; Taratula, O1
Gerasimova, GK; Kaliya, OL; Lukyanets, EA; Posypanova, GA; Severin, ES; Severin, SE; Shmyrev, II; Vorozhtsov, GN; Zhukova, OS1
Krebs, D; Oehr, P; Schmidt, S; Wagner, U1

Other Studies

6 other study(ies) available for phthalocyanine and Ovarian Neoplasms

ArticleYear
Fluorescent Phthalocyanine-Encapsulated Bovine Serum Albumin Nanoparticles: Their Deployment as Therapeutic Agents in the NIR Region.
    Molecules (Basel, Switzerland), 2021, Aug-02, Volume: 26, Issue:15

    Topics: Cell Proliferation; Female; Humans; Indoles; Isoindoles; Light; Molecular Docking Simulation; Nanoparticles; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Serum Albumin, Bovine; Spectroscopy, Near-Infrared; Tumor Cells, Cultured

2021
Phthalocyanine-doped polystyrene fluorescent nanocomposite as a highly selective biosensor for quantitative determination of cancer antigen 125.
    Talanta, 2019, Aug-15, Volume: 201

    Topics: Biomarkers, Tumor; Biosensing Techniques; CA-125 Antigen; Female; Fluorescence; Fluorescent Dyes; Humans; Indoles; Isoindoles; Limit of Detection; Membrane Proteins; Nanocomposites; Nickel; Ovarian Neoplasms; Polystyrenes; Spectrometry, Fluorescence

2019
Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:1

    Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Dose-Response Relationship, Radiation; Female; Humans; Immunoconjugates; Immunoglobulins, Intravenous; Immunotherapy; Indoles; Infrared Rays; Isoindoles; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation-Sensitizing Agents; Trastuzumab

2015
ROS-induced nanotherapeutic approach for ovarian cancer treatment based on the combinatorial effect of photodynamic therapy and DJ-1 gene suppression.
    Nanomedicine : nanotechnology, biology, and medicine, 2015, Volume: 11, Issue:8

    Topics: Animals; Cell Line, Tumor; Dendrimers; Drug Carriers; Drug Delivery Systems; Female; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Isoindoles; Mice; Mice, Nude; Nanostructures; Oncogene Proteins; Ovarian Neoplasms; Ovary; Photochemotherapy; Photosensitizing Agents; Protein Deglycase DJ-1; Reactive Oxygen Species; RNA, Small Interfering; RNAi Therapeutics

2015
Antitumor activity of conjugates of the oncofetal protein alpha-fetoprotein and phthalocyanines in vitro.
    Biochemistry and molecular biology international, 1997, Volume: 43, Issue:5

    Topics: alpha-Fetoproteins; Aluminum; Antineoplastic Agents; Cobalt; Female; Humans; Immunotoxins; Indoles; Isoindoles; Lymphocytes; Neuroblastoma; Organometallic Compounds; Ovarian Neoplasms; Oxidants, Photochemical; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1997
[Clinical use of photodynamic therapy in gynecologic tumor patients--antibody-targeted photodynamic laser therapy as a new oncologic treatment procedure].
    Zentralblatt fur Gynakologie, 1992, Volume: 114, Issue:6

    Topics: Combined Modality Therapy; Female; Humans; Immunotoxins; Indoles; Isoindoles; Lasers; Neoplasm Staging; Ovarian Neoplasms; Ovary; Photochemotherapy

1992